
### [NCIT:C7173](http://purl.obolibrary.org/obo/NCIT_C7173)
**Label:** Diffuse Astrocytoma

**Subclasses:** [NCIT:C114967](http://purl.obolibrary.org/obo/NCIT_C114967) (Childhood Diffuse Astrocytoma), [NCIT:C129272](http://purl.obolibrary.org/obo/NCIT_C129272) (Gemistocytic Astrocytoma, IDH-Mutant), [NCIT:C114964](http://purl.obolibrary.org/obo/NCIT_C114964) (Childhood Gemistocytic Astrocytoma), [NCIT:C129271](http://purl.obolibrary.org/obo/NCIT_C129271) (Diffuse Astrocytoma, IDH-Mutant), [NCIT:C4322](http://purl.obolibrary.org/obo/NCIT_C4322) (Fibrillary Astrocytoma), [NCIT:C114963](http://purl.obolibrary.org/obo/NCIT_C114963) (Childhood Fibrillary Astrocytoma), [NCIT:C114972](http://purl.obolibrary.org/obo/NCIT_C114972) (Childhood Protoplasmic Astrocytoma), [NCIT:C115376](http://purl.obolibrary.org/obo/NCIT_C115376) (Recurrent Childhood Protoplasmic Astrocytoma), [NCIT:C4320](http://purl.obolibrary.org/obo/NCIT_C4320) (Protoplasmic Astrocytoma), [NCIT:C4321](http://purl.obolibrary.org/obo/NCIT_C4321) (Gemistocytic Astrocytoma), [NCIT:C115362](http://purl.obolibrary.org/obo/NCIT_C115362) (Recurrent Childhood Gemistocytic Astrocytoma), [NCIT:C115361](http://purl.obolibrary.org/obo/NCIT_C115361) (Recurrent Childhood Fibrillary Astrocytoma), [NCIT:C7174](http://purl.obolibrary.org/obo/NCIT_C7174) (Adult Diffuse Astrocytoma), [NCIT:C8387](http://purl.obolibrary.org/obo/NCIT_C8387) (Childhood Cerebral Diffuse Astrocytoma), [NCIT:C115360](http://purl.obolibrary.org/obo/NCIT_C115360) (Recurrent Childhood Diffuse Astrocytoma), [NCIT:C129277](http://purl.obolibrary.org/obo/NCIT_C129277) (Diffuse Astrocytoma, Not Otherwise Specified), [NCIT:C129274](http://purl.obolibrary.org/obo/NCIT_C129274) (Diffuse Astrocytoma, IDH-Wildtype), 

**Class expressions from DL-Learner:**

- Thing 54.16%
- [NCIT:C28078](http://purl.obolibrary.org/obo/NCIT_C28078) (Grade 2) 51.85%
- [NCIT:C14161](http://purl.obolibrary.org/obo/NCIT_C14161) (Low Grade) 51.85%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C14158](http://purl.obolibrary.org/obo/NCIT_C14158) (High Grade))) 51.85%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C40015](http://purl.obolibrary.org/obo/NCIT_C40015) (Ovarian Mucinous Carcinoid Tumor))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C40014](http://purl.obolibrary.org/obo/NCIT_C40014) (Ovarian Trabecular Carcinoid Tumor))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39991](http://purl.obolibrary.org/obo/NCIT_C39991) (Non-Gestational Ovarian Choriocarcinoma))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39989](http://purl.obolibrary.org/obo/NCIT_C39989) (Ovarian Yolk Sac Tumor, Hepatoid Pattern))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39988](http://purl.obolibrary.org/obo/NCIT_C39988) (Ovarian Yolk Sac Tumor, Glandular Pattern))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39985](http://purl.obolibrary.org/obo/NCIT_C39985) (Ovarian Gonadoblastoma))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C3998](http://purl.obolibrary.org/obo/NCIT_C3998) (Recurrent Colon Carcinoma))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39966](http://purl.obolibrary.org/obo/NCIT_C39966) (Ovarian Sertoli-Stromal Cell Tumor))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39963](http://purl.obolibrary.org/obo/NCIT_C39963) (Penile Bowenoid Papulosis))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39961](http://purl.obolibrary.org/obo/NCIT_C39961) (Penile Basal Cell Carcinoma))) 37.21%


